Rentschler Announces 2. Laupheimer Zelltage on Industrial Cell Culture Technology
News Jan 31, 2012
Rentschler Biotechnologie GmbH has announced the second Laupheimer Zelltage , a biennial industrial cell culture technology conference to be held on June 11-12, 2012 at Laupheim's historical castle, Schloss Großlaupheim.
The aim of the Laupheimer Zelltage conferences is to provide comprehensive scientific updates on cutting-edge technologies and to discuss application-oriented topics as a means to advance protein and virus-based biologics production.
The conference will bring together 200 academic and industrial experts on cell culture and process technology from all over the world. The official conference language is English.
The theme of the second Laupheimer Zelltage is “Bioprocess light”. The conference will focus on key factors that allow fast, robust, economically competitive processes.
One of the sessions will be on “New Targets for Animal Cell Technology” with lectures covering increase of productivity (Dr. Martin Gawlitzek, Genentech Inc., San Francisco, USA), the prediction of productivity by gene expression analysis (Prof. Martin Clynes, Dublin City University, Ireland) and virus-based biologics as new product candidates (Dr. Markus Hörer, Rentschler Biotechnologie GmbH, Germany).
The keynote lecture will be held by Prof. Manuel Carrondo (IBET, Portugal).
“Based on the success of the inaugural conference in 2010, we’ll keep the conference’s focus on the industrial aspects of cell culture technology. As one of the few conferences with this focus, the Laupheimer Zelltage is a vital opportunity to learn about trends and hear thoughtful inputs on mastering the challenges of industrial cell culture process development,” says Prof. Roland Wagner, Senior Vice President at Rentschler.
On June 11, before the first session of the conference, attendees will have the opportunity to visit Rentschler's new 1,000 L single-use facility that has recently been recognized with the 2012 Facility of the Year Award (FOYA) in the category ‘Equipment Innovation’.
Human Pluripotent Stem Cells Successfully 3D PrintedNews
A breakthrough in the 3D-printing of human pluripotent stem cells means scientists are one step closer to being able to 3D print human organs and tissues for transplantation therapy.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018